Hims & Hers Health, Inc. (HIMS) Stock
HIMS Key Statistics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
CEO: Andrew Dudum. Company website
HIMS — Frequently Asked Questions
What is the HIMS stock price today?
Hims & Hers Health, Inc. (HIMS) trades at $20.81, up 8.78% on the day, as of Nov 12, 2026 09:30 UTC.
What is Hims & Hers Health, Inc.'s market cap?
Hims & Hers Health, Inc. has a market capitalisation of $4.68B, calculated from the live HIMS share price and shares outstanding.
What is the P/E ratio of HIMS?
HIMS has no meaningful price-to-earnings ratio: Hims & Hers Health, Inc. lost $0.84 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Hims & Hers Health, Inc. make?
Hims & Hers Health, Inc. generated revenue of $2.87B over the trailing twelve months, which puts the stock at 1.63 times sales.
What is the 52-week range for HIMS?
HIMS has traded between $13.74 and $42.70 over the past 52 weeks, and the last price is 51.3% below that high.
Is Hims & Hers Health, Inc. profitable?
No. Hims & Hers Health, Inc. is loss-making, with a net margin of -6.65% over the trailing twelve months.
What is the analyst price target for HIMS?
Wall Street analysts rate HIMS Hold, with an average price target of $32.17, 54.6% above the current price.
What sector is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.
Who is the CEO of Hims & Hers Health, Inc.?
Andrew Dudum is the chief executive of Hims & Hers Health, Inc., which employs 2,442 people.
Where can I track HIMS in real time?
QFI Terminal shows HIMS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See HIMS live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open HIMS in Terminal See plans